Signature Wealth Management Partners, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Signature Wealth Management Partners, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$281,331
+3.5%
66,666
-24.0%
0.28%
+9.1%
Q2 2023$271,765
+123.0%
87,6660.0%0.25%
+123.0%
Q1 2023$121,856
-30.2%
87,6660.0%0.11%
-34.3%
Q4 2022$174,455
-1.4%
87,6660.0%0.17%
-11.8%
Q3 2022$177,000
-36.6%
87,6660.0%0.20%
-31.8%
Q2 2022$279,000
-23.8%
87,6660.0%0.29%
-8.3%
Q1 2022$366,000
-12.9%
87,6660.0%0.31%
-12.4%
Q4 2021$420,000
-10.3%
87,6660.0%0.36%
-16.0%
Q3 2021$468,000
+4.2%
87,6660.0%0.42%
+3.9%
Q2 2021$449,000
-23.9%
87,6660.0%0.41%
-27.9%
Q1 2021$590,000
+47.1%
87,6660.0%0.57%
+41.1%
Q4 2020$401,00087,6660.40%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders